Related Experiment Video
Updated: Apr 3, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
Immunotherapy of Brain Tumors
New immunotherapies, including vaccines and cell therapies targeting glioma, are showing promise. Combining these with microenvironment modulation may revolutionize brain tumor treatment.
Area of Science:
- Neuro-oncology
- Cancer Immunology
- Immunotherapy
Background:
- Glioma is a devastating brain cancer with poor prognosis due to invasive cell growth.
- Brain immune responses share similarities with other tissues, enabling immunotherapy development.
- Current glioma treatments are limited by tumor cell invasion.
Purpose of the Study:
- To review current and emerging immunotherapeutic strategies for glioma.
- To explore the potential of combining different immunotherapy approaches for brain tumors.
Main Methods:
- Vaccine strategies utilizing tumor-specific mutated peptides (e.g., EGFRvIII, IDH1) or tumor-derived peptides.
- Cell therapy approaches, including T cells with chimeric antigen receptors (CARs) targeting glioma antigens (e.g., EGFRvIII, IL-13Rα2, Her2).
- Strategies to modulate the glioma microenvironment, such as TGFβ inhibition, Treg depletion, and immune checkpoint blockade.
Main Results:
- Vaccines using various peptide types are being investigated.
- Early clinical trials for CAR T-cell therapy in glioma are underway.
- Microenvironment-modulating therapies are in development.
Conclusions:
- Immunotherapy offers a promising avenue for treating aggressive gliomas.
- Combination therapies integrating vaccines, cell therapy, and microenvironment modulation are essential for future brain tumor therapeutics.
More Related Videos
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
12:52Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...